Published on September 26th, 2012 | by Steven Hodson0
Earlier Detection Of Parkinson’s Disease Getting Much Closer Say Researchers
Based on close co-operation between a Roche medical chemist Ludmilla Morozova, the research team at Umeå University lead by Lars Forsgren, and a team at Oxford University lead by Jason Davis doctors may be able to soon detect Parkinson’s disease at a much earlier stage.
It was back in 2011 when the Umeå scientists were able to determine endogenous antibodies against the most important amyloid protein, alpha-synuclein. Amyloids are created when proteins are lumped together and then in the case of Parkinson’s attack the nervous system.
These antibodies are seen as being able to function as a diagnostic marker making it easier to detect the disease at an earlier stage than before. This is accomplished using a simplified way to measure the contents of antibodies in a blood sample and with this new way it is possible to see a clear difference between individuals with incipient Parkinson’s and the healthy controls. Additionally this method can be used to measure and establish the advance of the disease with much greater accuracy.